• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Brooks Laboratories Ltd

+ Add to Watchlist

BKL:IN

50.75 INR 3.80 8.09%

As of 06:05:46 ET on 11/21/2014.

Snapshot for Brooks Laboratories Ltd (BKL)

Open: 48.45 Day's Range: 46.10 - 53.35 Volume: 1,358,319
Previous Close: 46.95 52wk Range: 15.95 - 53.60 1-Yr Rtn: +202.08%

Stock Chart for BKL

No chart data available.
  • BKL:IN 50.75
  • 1D
  • 1M
  • 1Y
46.95
Interactive BKL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BKL

Current P/E Ratio (ttm) 9.2969
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.4755
Earnings Per Share (ttm) 5.4588
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 821.46
Shares Outstanding (M) 16.19
30 Day Average Volume 251,264
Price/Book (mrq) 0.9001
Price/Sale (ttm) 0.9636
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BKL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for BKL

Brooks Laboratories Limited is a research and development driven pharmaceutical manufacturing company. The Company is a contract manufacturing company for the latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Rajesh MahajanManaging Director/Co-FounderAtul RanchalChairman/Executive Director
Durga Sankar MaityCEO/Exec Dir/Technical DirectorAnil PillaiChief Financial Officer
More Company Profile & Key Executives for BKL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil